71 related articles for article (PubMed ID: 15733465)
1. [Inhibitory effect of recombinant transforming growth factor alpha-pseudomonas exotoxin 40 on human bladder cancer cell proliferation].
Yan X; Ding Q; Zhang YF; Xu YH
Zhonghua Wai Ke Za Zhi; 2004 Dec; 42(23):1457-9. PubMed ID: 15733465
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of recombinant TGF alpha-PE40 on vascular smooth muscle cell proliferation.
Wang B; Guan ZJ; Zhang GY; Wu ZG; Xu YH; Jiang WL; Rui YC; Chu ZY
Zhongguo Yao Li Xue Bao; 1999 Sep; 20(9):795-9. PubMed ID: 11245086
[TBL] [Abstract][Full Text] [Related]
3. Activity of a recombinant transforming growth factor-alpha-Pseudomonas exotoxin hybrid protein against primary human tumor colony-forming units.
Von Hoff DD; Marshall MH; Heimbrook DC; Stirdivant SM; Ahern JD; Herbert WK; Maigetter RZ; Oliff A
Invest New Drugs; 1992 Apr; 10(1):17-22. PubMed ID: 1607249
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of recombinant TGFalpha-PE40 on neointimal proliferation after arterial balloon injury.
Wang B; Xu YH; Li YL; Zhang GY; Jiang WL; Rui YC; Wu ZG
Acta Pharmacol Sin; 2001 Jan; 22(1):15-20. PubMed ID: 11730555
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic effects of TGF-alpha-Pseudomonas exotoxin A fusion protein in human pancreatic carcinoma cells.
Baldwin RL; Kobrin MS; Tran T; Pastan I; Korc M
Pancreas; 1996 Jul; 13(1):16-21. PubMed ID: 8783329
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic effect of a fusion protein from transforming growth factor alpha and Pseudomonas exotoxin on rat and human bladder carcinoma cells in vitro.
Kameyama S; Kawamata H; Pastan I; Oyasu R
J Cancer Res Clin Oncol; 1994; 120(9):507-12. PubMed ID: 8045915
[TBL] [Abstract][Full Text] [Related]
7. Phase I clinical study of the recombinant oncotoxin TP40 in superficial bladder cancer.
Goldberg MR; Heimbrook DC; Russo P; Sarosdy MF; Greenberg RE; Giantonio BJ; Linehan WM; Walther M; Fisher HA; Messing E
Clin Cancer Res; 1995 Jan; 1(1):57-61. PubMed ID: 9815887
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer.
Dominguez-Escrig JL; Kelly JD; Neal DE; King SM; Davies BR
Clin Cancer Res; 2004 Jul; 10(14):4874-84. PubMed ID: 15269164
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.
Arteaga CL; Hurd SD; Dugger TC; Winnier AR; Robertson JB
Cancer Res; 1994 Sep; 54(17):4703-9. PubMed ID: 8062268
[TBL] [Abstract][Full Text] [Related]
10. A transforming growth factor-alpha-Pseudomonas exotoxin hybrid protein undergoes pH-dependent conformational changes conducive to membrane interaction.
Sanyal G; Marquis-Omer D; Gress JO; Middaugh CR
Biochemistry; 1993 Apr; 32(13):3488-97. PubMed ID: 8461310
[TBL] [Abstract][Full Text] [Related]
11. Diphtheria toxin-epidermal growth factor fusion protein and Pseudomonas exotoxin-interleukin 13 fusion protein exert synergistic toxicity against human glioblastoma multiforme cells.
Liu TF; Willingham MC; Tatter SB; Cohen KA; Lowe AC; Thorburn A; Frankel AE
Bioconjug Chem; 2003; 14(6):1107-14. PubMed ID: 14624623
[TBL] [Abstract][Full Text] [Related]
12. Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy.
Funatomi H; Itakura J; Ishiwata T; Pastan I; Thompson SA; Johnson GR; Korc M
Int J Cancer; 1997 Jul; 72(3):512-7. PubMed ID: 9247297
[TBL] [Abstract][Full Text] [Related]
13. A recombinant form of Pseudomonas exotoxin A containing transforming growth factor alpha near its carboxyl terminus for the treatment of bladder cancer.
Theuer CP; FitzGerald DJ; Pastan I
J Urol; 1993 Jun; 149(6):1626-32. PubMed ID: 8501821
[TBL] [Abstract][Full Text] [Related]
14. Interferon alpha2 recombinant and epidermal growth factor modulate proliferation and hypusine synthesis in human epidermoid cancer KB cells.
Caraglia M; Passeggio A; Beninati S; Leardi A; Nicolini L; Improta S; Pinto A; Bianco AR; Tagliaferri P; Abbruzzese A
Biochem J; 1997 Jun; 324 ( Pt 3)(Pt 3):737-41. PubMed ID: 9210396
[TBL] [Abstract][Full Text] [Related]
15. Two- and three-dimensional cell structures govern epidermal growth factor survival function in human bladder carcinoma cell lines.
Dangles V; Féménia F; Lainé V; Berthelemy M; Le Rhun D; Poupon MF; Levy D; Schwartz-Cornil I
Cancer Res; 1997 Aug; 57(16):3360-4. PubMed ID: 9269996
[TBL] [Abstract][Full Text] [Related]
16. In vitro sensitivity testing of human bladder cancers and cell lines to TP-40, a hybrid protein with selective targeting and cytotoxicity.
Sarosdy MF; Hutzler DH; Yee D; von Hoff DD
J Urol; 1993 Dec; 150(6):1950-5. PubMed ID: 8230543
[TBL] [Abstract][Full Text] [Related]
17. A toxin conjugate containing transforming growth factor-alpha and ricin A specifically inhibits growth of A431 human epidermoid cancer cells.
Fang K
Proc Natl Sci Counc Repub China B; 1998 Apr; 22(2):76-82. PubMed ID: 9615470
[TBL] [Abstract][Full Text] [Related]
18. Small chimeric toxins containing only transforming growth factor alpha and domain III of Pseudomonas exotoxin with good antitumor activity in mice.
Kihara A; Pastan I
Cancer Res; 1994 Oct; 54(19):5154-9. PubMed ID: 7923133
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of a transforming growth factor alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE40).
Pai LH; Gallo MG; FitzGerald DJ; Pastan I
Cancer Res; 1991 Jun; 51(11):2808-12. PubMed ID: 2032221
[TBL] [Abstract][Full Text] [Related]
20. Recombinant heregulin-Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivo.
Yang D; Kuan CT; Payne J; Kihara A; Murray A; Wang LM; Alimandi M; Pierce JH; Pastan I; Lippman ME
Clin Cancer Res; 1998 Apr; 4(4):993-1004. PubMed ID: 9563895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
